CRO support for ncats in vitro and in vivo toxicology studies
Ended Awarded Last action
- Contract number
- HHSN271201700017I
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $8,184,034 obligated
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR172002 · Posted Apr 7, 2020
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Award Notice · Posted May 2, 2016
- Combined order value
-
- $8,184,034 Current, with exercised options
- $10,984,003 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 21% used
- $39,804,016.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$6,500 | |
| Original award | $6,500 |
Quick answers
Who was awarded contract HHSN271201700017I?
HHSN271201700017I was awarded to Lovelace Biomedical Research Institute by National Institute on Drug Abuse (National Institutes of Health) on April 21, 2017.
How much is contract HHSN271201700017I worth?
Orders under HHSN271201700017I have obligated $8,184,034. Their combined potential value, with all options, is $10,984,003. HHSN271201700017I's own ceiling is $39,804,016.
How many orders have been placed under contract HHSN271201700017I?
3 orders have been placed under HHSN271201700017I, the latest on September 25, 2020.
Which agency awarded contract HHSN271201700017I?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201700017I, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Who can order from contract HHSN271201700017I?
HHSN271201700017I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN271201700017I part of a contract vehicle?
Yes. HHSN271201700017I is part of CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract HHSN271201700017I competed?
The extent of competition for HHSN271201700017I was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV